RJA
BDSI

Raymond James & Associates’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Raymond James & Associates’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-94,147
Closed -$292K – 4376
2021
Q4 		$292K Buy
94,147
+13,088
+16% +$44K ﹤0.01% 3458
2021
Q3 		$293K Sell
81,059
-1,000
-1% -$3.77K ﹤0.01% 3428
2021
Q2 		$294K Buy
82,059
+9,359
+13% +$33K ﹤0.01% 3448
2021
Q1 		$284K Buy
72,700
+714
+1% +$2.95K ﹤0.01% 3399
2020
Q4 		$302K Buy
71,986
+7,500
+12% +$28.9K ﹤0.01% 3115
2020
Q3 		$241K Buy
64,486
+4,100
+7% +$17.4K ﹤0.01% 3090
2020
Q2 		$263K Sell
60,386
-10,300
-15% -$46.3K ﹤0.01% 2993
2020
Q1 		$268K Buy
70,686
+4,919
+7% +$24.2K ﹤0.01% 2847
2019
Q4 		$416K Buy
65,767
+18,056
+38% +$106K ﹤0.01% 2866
2019
Q3 		$201K Buy
47,711
+1,500
+3% +$6.41K ﹤0.01% 3259
2019
Q2 		$215K Hold
46,211
– – ﹤0.01% 3209
2019
Q1 		$245K Hold
46,211
– – ﹤0.01% 3096
2018
Q4 		$171K Buy
46,211
+6,000
+15% +$21.1K ﹤0.01% 3195
2018
Q3 		$113K Buy
+40,211
New +$113K ﹤0.01% 3419
2016
Q4 		– Sell
-11,900
Closed -$32K – 3470
2016
Q3 		$32K Buy
+11,900
New +$30.2K ﹤0.01% 3110

Other funds holding BDSI

CAM
Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return
FCMT
Founders Capital Management (Texas) Houston, Texas $231M AUM 61.68% 1-Year Est. Return

Raymond James & Associates's BDSI Position: Q1 2022 in Review

Raymond James & Associates sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 94,147 shares — an estimated $292K sold.

Raymond James & Associates first reported a position in BDSI in Q3 2016 and held it in 15 quarters. The position peaked at $416K in Q4 2019. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.

  • Raymond James & Associates reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
  • Raymond James & Associates sold 94,147 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $292K.
  • Raymond James & Associates first reported a position in BioDelivery Sciences International, Inc. in Q3 2016 and held it in 15 quarters.
  • Raymond James & Associates's BioDelivery Sciences International, Inc. position peaked at $416K in Q4 2019.
  • 2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.

Based on Raymond James & Associates's 13F filing for Q1 2022, filed 11 May 2022.